Lh. Cohen et al., DIFFERENT ANALOGS OF FARNESYL PYROPHOSPHATE INHIBIT SQUALENE SYNTHASEAND PROTEIN-FARNESYLTRANSFERASE TO DIFFERENT EXTENTS, Biochemical pharmacology, 49(6), 1995, pp. 839-845
The inhibitory potency of farnesyl pyrophosphate analogues was investi
gated on two farnesyl pyrophosphate-consuming enzymes: squalene syntha
se, a secondary regulation site in the cholesterol synthesis pathway,
and protein:farnesyl transferase, which plays a role in the function o
f Ras-proteins. For the transferase determination a rapid in vitro ass
ay, using Sepharose-bound Ras-peptides, was developed. The distinct fa
rnesyl pyrophosphate analogues showed a different order of potency in
the inhibition of these two enzymes. Using the farnesyl transferase as
say with pre-p21(Ha-ras) as substrate the same result was obtained. Th
e difference observed in the in vitro assays was also reflected in the
inhibition of cholesterol synthesis, protein prenylation in general a
nd Ha-ras farnesylation in Rat-1.H-ras13 cells, a rat fibroblast cell
line that overproduces human p21(Ha-ras) This work shows that farnesyl
pyrophosphate analogues can be developed for specific inhibition of d
ifferent processes such as cholesterol synthesis and protein prenylati
on.